JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Complete mRNA Solutions

Our new facility expansion will enable TriLink to offer custom plasmid DNA production services, as well as enhanced scale-up manufacturing of CleanCap^® mRNA capping solutions and small molecules.

Learn more

Custom and stocked solutions for COVID-19 programs.

CleanCap^®mRNA for rapid vaccine development and top-tier oligos to power diagnostic kits

CleanCap^® sets a new standard for superior mRNA translation.

Find out how CleanCap^® technology reduces cost while increasing efficiency.

Learn More

About TriLink BioTechnologies

TriLink BioTechnologies, part of Maravai LifeSciences, is a CDMO helping life science leaders and innovators overcome challenges in the synthesis and scale-up of nucleic acids, NTPs and mRNA capping analogs with scale-up expertise and unique mRNA production capabilities, including its proprietary CleanCap^® mRNA capping technology. TriLink continues to expand its cGMP and general mRNA, oligonucleotide & plasmid manufacturing capacity at its new global headquarters to support therapeutic, vaccine and diagnostic customers.